Literature DB >> 25848012

Structure of CARDS toxin, a unique ADP-ribosylating and vacuolating cytotoxin from Mycoplasma pneumoniae.

Argentina Becker1, T R Kannan2, Alexander B Taylor3, Olga N Pakhomova4, Yanfeng Zhang1, Sudha R Somarajan2, Ahmad Galaleldeen5, Stephen P Holloway1, Joel B Baseman6, P John Hart7.   

Abstract

Mycoplasma pneumoniae (Mp) infections cause tracheobronchitis and "walking" pneumonia, and are linked to asthma and other reactive airway diseases. As part of the infectious process, the bacterium expresses a 591-aa virulence factor with both mono-ADP ribosyltransferase (mART) and vacuolating activities known as Community-Acquired Respiratory Distress Syndrome Toxin (CARDS TX). CARDS TX binds to human surfactant protein A and annexin A2 on airway epithelial cells and is internalized, leading to a range of pathogenetic events. Here we present the structure of CARDS TX, a triangular molecule in which N-terminal mART and C-terminal tandem β-trefoil domains associate to form an overall architecture distinct from other well-recognized ADP-ribosylating bacterial toxins. We demonstrate that CARDS TX binds phosphatidylcholine and sphingomyelin specifically over other membrane lipids, and that cell surface binding and internalization activities are housed within the C-terminal β-trefoil domain. The results enhance our understanding of Mp pathogenicity and suggest a novel avenue for the development of therapies to treat Mp-associated asthma and other acute and chronic airway diseases.

Entities:  

Keywords:  ADP-ribosyltransferase; mycoplasma cytotoxin; reactive airway disease; single-crystal X-ray diffraction; vacuolation

Mesh:

Substances:

Year:  2015        PMID: 25848012      PMCID: PMC4413325          DOI: 10.1073/pnas.1420308112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation.

Authors:  Jorge L Medina; Jacqueline J Coalson; Edward G Brooks; Vicki T Winter; Adriana Chaparro; Molly F R Principe; Thirumalai R Kannan; Joel B Baseman; Peter H Dube
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01-26       Impact factor: 6.914

2.  Crystallization of community-acquired respiratory distress syndrome toxin from Mycoplasma pneumoniae.

Authors:  Olga N Pakhomova; Alexander B Taylor; Argentina Becker; Stephen P Holloway; T R Kannan; Joel B Baseman; P John Hart
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-02-24

Review 3.  Mycoplasma pneumoniae and its role in asthma.

Authors:  Nazima Nisar; Randeep Guleria; Sanjay Kumar; Tirlok Chand Chawla; Nihar Ranjan Biswas
Journal:  Postgrad Med J       Date:  2007-02       Impact factor: 2.401

4.  ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens.

Authors:  T R Kannan; Joel B Baseman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-14       Impact factor: 11.205

5.  Mycoplasma pneumoniae Community Acquired Respiratory Distress Syndrome toxin expression reveals growth phase and infection-dependent regulation.

Authors:  T R Kannan; Oxana Musatovova; Sowmya Balasubramanian; Marianna Cagle; Jarrat L Jordan; Thomas M Krunkosky; Alan Davis; Robert D Hardy; Joel B Baseman
Journal:  Mol Microbiol       Date:  2010-02-28       Impact factor: 3.501

6.  Mycoplasma antigens as a possible trigger for the induction of antimitochondrial antibodies in primary biliary cirrhosis.

Authors:  Christoph P Berg; Thirumalai R Kannan; Reinhild Klein; Michael Gregor; Joel B Baseman; Sebastian Wesselborg; Kirsten Lauber; Gerburg M Stein
Journal:  Liver Int       Date:  2009-07       Impact factor: 5.828

7.  The three-dimensional crystal structure of cholera toxin.

Authors:  R G Zhang; D L Scott; M L Westbrook; S Nance; B D Spangler; G G Shipley; E M Westbrook
Journal:  J Mol Biol       Date:  1995-08-25       Impact factor: 5.469

8.  Cellular vacuoles induced by Mycoplasma pneumoniae CARDS toxin originate from Rab9-associated compartments.

Authors:  Coreen Johnson; T R Kannan; Joel B Baseman
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

9.  Mechanisms of assembly and cellular interactions for the bacterial genotoxin CDT.

Authors:  Dragana Nesic; C Erec Stebbins
Journal:  PLoS Pathog       Date:  2005-11-18       Impact factor: 6.823

10.  ADP-ribosylation of NLRP3 by Mycoplasma pneumoniae CARDS toxin regulates inflammasome activity.

Authors:  Santanu Bose; Jesus A Segovia; Sudha R Somarajan; Te-Hung Chang; T R Kannan; Joel B Baseman
Journal:  MBio       Date:  2014-12-23       Impact factor: 7.867

View more
  30 in total

Review 1.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Disulfide bond of Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin is essential to maintain the ADP-ribosylating and vacuolating activities.

Authors:  Sowmya Balasubramanian; Lavanya Pandranki; Suzanna Maupin; Kumaraguruparan Ramasamy; Alexander B Taylor; Peter John Hart; Joel B Baseman; Thirumalai R Kannan
Journal:  Cell Microbiol       Date:  2019-05-09       Impact factor: 3.715

3.  NLRP3 Is a Critical Regulator of Inflammation and Innate Immune Cell Response during Mycoplasma pneumoniae Infection.

Authors:  Jesus A Segovia; Te-Hung Chang; Vicki T Winter; Jacqueline J Coalson; Marianna P Cagle; Lavanya Pandranki; Santanu Bose; Joel B Baseman; Thirumalai R Kannan
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

4.  SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases.

Authors:  Gonzalo Ferreira; Axel Santander; Florencia Savio; Mariana Guirado; Luis Sobrevia; Garth L Nicolson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-09-03       Impact factor: 5.187

5.  MIB-MIP is a mycoplasma system that captures and cleaves immunoglobulin G.

Authors:  Yonathan Arfi; Laetitia Minder; Carmelo Di Primo; Aline Le Roy; Christine Ebel; Laurent Coquet; Stephane Claverol; Sanjay Vashee; Joerg Jores; Alain Blanchard; Pascal Sirand-Pugnet
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

6.  Mycoplasma pneumoniae CARDS toxin exploits host cell endosomal acidic pH and vacuolar ATPase proton pump to execute its biological activities.

Authors:  Kumaraguruparan Ramasamy; Sowmya Balasubramanian; Alejandra Kirkpatrick; Daniel Szabo; Lavanya Pandranki; Joel B Baseman; T R Kannan
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.379

7.  Comparative "-omics" in Mycoplasma pneumoniae Clinical Isolates Reveals Key Virulence Factors.

Authors:  Maria Lluch-Senar; Luca Cozzuto; Jaime Cano; Javier Delgado; Verónica Llórens-Rico; Sabine Pereyre; Cécile Bebear; Luis Serrano
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

Review 8.  A Compendium for Mycoplasma pneumoniae.

Authors:  Gretchen L Parrott; Takeshi Kinjo; Jiro Fujita
Journal:  Front Microbiol       Date:  2016-04-12       Impact factor: 5.640

Review 9.  Infection with and Carriage of Mycoplasma pneumoniae in Children.

Authors:  Patrick M Meyer Sauteur; Wendy W J Unger; David Nadal; Christoph Berger; Cornelis Vink; Annemarie M C van Rossum
Journal:  Front Microbiol       Date:  2016-03-23       Impact factor: 5.640

Review 10.  Potential Molecular Targets for Narrow-Spectrum Agents to Combat Mycoplasma pneumoniae Infection and Disease.

Authors:  Mitchell F Balish; Steven L Distelhorst
Journal:  Front Microbiol       Date:  2016-02-25       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.